Search Clinical Trials ?


Trials Open: 4
Cancer Type: Multiple Myeloma
Protocol No.Title
16-MYEL-10/M15-53816-MYEL-10-AB/M15-538: A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma.
MCC-16-MULTI-18Genomic Testing for Patients with Refractory Cancer to Determine Treatment
MCC-16-MULTI-19Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies